Routine dividend reinvestment by PDMRs, no signal for future performance. Monitor next quarterly earnings for fundamental updates on revenue and pipeline progress.
Price Chart
Executive Summary
GSK filed a routine 6-K reporting that three senior executives (SVP & Group General Counsel, President US, and Chief Digital & Technology Officer) acquired small amounts of ADS through dividend reinvestment on October 13, 2026. The transactions are mechanical, not discretionary open-market purchases, and involve negligible dollar amounts totaling approximately $65,900.
Key Facts
- James Ford (SVP & Group General Counsel) acquired 326.441 ADS at $46.9482/share via dividend reinvestment on 2026-10-13.
- Maya Martinez-Davis (President, US) acquired 351.842 ADS at $46.9482/share via dividend reinvestment on 2026-10-13.
- Shobie Ramakrishnan (Chief Digital and Technology Officer) acquired 724.875 ADS at $46.9482/share via dividend reinvestment on 2026-10-13.
- Total acquisition value across all three executives is approximately $65,900.
- All transactions were executed on the NYSE and are automatic dividend reinvestments, not discretionary insider buys.
Financial Impact
Total ADS acquired: ~1,403 shares at ~$46.95/share, aggregate value ~$65,900, immaterial for a company of GSK's size.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-008959 |
| Document: 0001654954-26-008959-index-headers.html | 0001654954-26-008959 |
| Document: 0001654954-26-008959-index.html | 0001654954-26-008959 |
| Document: 0001654954-26-008959.txt | 0001654954-26-008959 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | 6-K | $49.07 | awaiting T+5 | awaiting T+5 | $48.74 (−0.67%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 21, 2026 7d ago | 6-K | $50.02 $50.94 | ▲ +1.84% | ▲ +2.28% | $48.74 (−2.56%) |
Oct 19, 2026 9d ago | 6-K | $49.46 $51.10 | ▲ +3.32% | ▲ +3.46% | $48.74 (−1.46%) |
Oct 19, 2026 9d ago | 6-K | $49.46 $51.10 | ▲ +3.32% | ▲ +3.46% | $48.74 (−1.46%) |
Oct 15, 2026 13d ago | 6-K | $49.02 $51.21 | ▲ +4.47% | ▲ +5.48% | $48.74 (−0.57%) |
Oct 14, 2026 14d ago | 6-K | $47.87 $50.02 | ▲ +4.49% | ▲ +4.04% | $48.74 (+1.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers